Expect an increase in demand for long-acting injectable buprenorphine

0
Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

Changes to PBS antibiotic prescribing

0
In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...

Assessing and managing sore throat

0
Sore throat is a symptom rather than a diagnosis. Although usually mild it can be painful and warrants careful investigation by pharmacists.

TGA approves Pfizer booster for teens

0
Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Therapeutic contact lenses: the future of drug delivery?

0
A novel therapy under investigation could see pharmacists playing a greater role in helping patients to manage some common eye conditions.

Meet the newest members of PSA’s leadership team

0
The results of PSA’s Branch elections are in, with three innovative new leaders chosen to steer the profession through challenging times.